Recombinant Human B7-2/CD86 His Tag Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 9090-B2

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
9090-B2-01M
9090-B2-100
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

HEK293

Accession #

NP_787058

Conjugate

Unconjugated

Applications

Bioactivity

View all B7-2/CD86 Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human B7-2/CD86 protein
Leu26-Pro247, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Leu26

Predicted Molecular Mass

26 kDa

SDS-PAGE

57-66 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human B7-2/CD86 is coated at 0.5 µg/mL, Recombinant Human CTLA-4 Fc Chimera  (Catalog # 7268-CT) binds with a typical ED50 of 7-42 ng/mL.

Scientific Data Images for Recombinant Human B7-2/CD86 His Tag Protein, CF

Recombinant Human B7-2/CD86 His Tag Protein Bioactivity

Recombinant Human B7-2/CD86 His Tag Protein Bioactivity

When Recombinant Human B7-2/CD86 (9090-B2) is coated at 0.5 µg/mL, Recombinant Human CTLA-4 Fc Chimera (Catalog # 7268-CT) binds with a typical ED50 of 7-42 ng/mL.

Formulation, Preparation and Storage

9090-B2
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution
Reconstitute at 500 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: B7-2/CD86

B7-2, also known as CD86, B70, and ETC-1, is a 60-100 kDa variably glycosylated protein in the B7 family. B7 family members are transmembrane cell surface molecules that play important roles in immune activation and the maintenance of immune tolerance (1, 2). Mature human B7-2 consists of a 224 amino acid (aa) extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 61 aa cytoplasmic tail (3, 4). Within the ECD, human B7-2 shares 59% aa sequence identity with mouse and rat B7-2. Alternative splicing of human B7-2 generates additional isoforms that lack both Ig-like domains or a region that includes the transmembrane segment. B7-2 is highly expressed on activated antigen presenting cells (APC), e.g. B cells, dendritic cells, and monocytes (4-7), as well as on vascular endothelial cells (8). B7-2 and the closely related B7-1/CD80 exhibit overlapping but distinct functional properties. Their binding to CD28, which is constitutively expressed on T cells, enhances T cell receptor signaling and also provides TCR-independent co-stimulation (3-5, 7, 9-11). B7-1 and B7-2 additionally bind the CD28-related protein, CTLA-4, which is up-regulated and recruited to the immunological synapse (IS) at the onset of T cell activation (3-5, 7, 9, 10). CTLA-4 ligation inhibits the T cell response and supports regulatory T cell function (12). B7-2 is expressed earlier than B7-1 following APC activation (6), and both proteins bind with higher affinity to CTLA-4 than to CD28 (10). B7-2 promotes the stabilization of CD28 in the IS, while B7-1 is primarily responsible for promoting CTLA-4 recruitment and accumulation in the IS (13). The relative participation of B7-1 and B7-2 in T cell co-stimulation can also alter the Th1/Th2 bias of the immune response (14). Both B7-1 and B7-2 serve as cellular receptors for B species adenoviruses (15).

References

  1. Greenwald, R.J. et al. (2005) Annu. Rev. Immunol. 23:515.
  2. Bour-Jordan, H. et al. (2011) Immunol. Rev. 241:180.
  3. Freeman, G.J. et al. (1993) Science 262:909.
  4. Azuma, M. et al. (1993) Nature 366:76.
  5. Freeman, G.J. et al. (1993) J. Exp. Med. 178:2185.
  6. Lenschow, D.J. et al. (1993) Proc. Natl. Acad. Sci. USA 90:11054.
  7. Hathcock, K.S. et al. (1993) Science 262:905.
  8. Seino, K. et al. (1995) Int. Immunol. 7:1331.
  9. Chen, C. et al. (1994) J. Immunol. 152:4929.
  10. Lanier, L.L. et al. (1995) J. Immunol. 154:97.
  11. Rudd, C.E. et al. (2009) Immunol. Rev. 229:12.
  12. Wing, K. et al. (2011) Trends Immunol. 32:428.
  13. Pentcheva-Hoang, T. et al. (2004) Immunity 21:401.
  14. Kuchroo, V.K. et al. (1995) Cell 80:707.
  15. Short, J.J. et al. (2006) Virus Res. 122:144.

Alternate Names

B72, CD86

Entrez Gene IDs

942 (Human); 12524 (Mouse); 56822 (Rat); 102147235 (Cynomolgus Monkey)

Gene Symbol

CD86

UniProt

NP_787058

Additional B7-2/CD86 Products

Product Documents for Recombinant Human B7-2/CD86 His Tag Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human B7-2/CD86 His Tag Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.